CVS
41
-4
THC
60
-5
TXN
43
-5
HBI
58
3
DGX
48
11
JNJ
41
3
RRC
52
-6
CA
22
-3
CMS
60
2
HCA
48
-2
WM
74
-5
HSIC
45
5
MNST
45
-21
PSA
56
3
WMT
56
-4
WHR
65
-5
AN
50
-5
HIG
66
2
AMZN
61
-5
DOV
65
-4
CVS
41
-4
THC
60
-5
TXN
43
-5
HBI
58
3
DGX
48
11
JNJ
41
3
RRC
52
-6
CA
22
-3
CMS
60
2
HCA
48
-2
WM
74
-5
HSIC
45
5
MNST
45
-21
PSA
56
3
WMT
56
-4
WHR
65
-5
AN
50
-5
HIG
66
2
AMZN
61
-5
DOV
65
-4
Financhill
Back

iShares MSCI Thailand ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
8

THD
iShares MSCI Thailand ETF

Last Price:
63.30
Seasonality Move:
1.82%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.87
Seasonality Move:
17.03%
Sell
8
iShares MSCI Thailand ETF (THD) is a Sell

Is iShares MSCI Thailand ETF a Buy, Sell or Hold?

  • The current iShares MSCI Thailand ETF [THD] share price is $62.37. The Score for THD is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • THD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THD Stock Price Chart

What is iShares MSCI Thailand ETF's stock price today?

  • The iShares MSCI Thailand ETF share price today is $62.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THD is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

THD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 33.61 Sell
Chaikin Money Flow: 12091 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.95 - 68.13) Sell
Bollinger Bands (100): (56.79 - 67.39) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

THD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.67 Sell
20-day SMA: 65.38 Sell
50-day SMA: 66.8 Sell
200-day SMA: 60.33 Buy
8-day EMA: 63.49 Sell
20-day EMA: 64.95 Sell
50-day EMA: 65.09 Sell
200-day EMA: 62.32 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Thailand ETF Earnings Growth & THD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

iShares MSCI Thailand ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):